How Suppository Placement Changes Cannabinoid Exposure
Rectal delivery occupies a strange position in cannabinoid discussions. It is taken seriously enough to generate real interest, yet rarely examined with the precision the anatomy demands. Most accounts treat it as a variation on oral delivery: material placed inside the body, expected to move inward, assumed to be heading toward systemic circulation by a more internal and therefore more efficient path. The underlying model is one of simple proximity: closer to the body's interior means closer to the bloodstream. Placement, in that model, is incidental. What matters is the compound, the dose, and the route category.
That model is where the misreading begins. Rectal delivery is not oral delivery repositioned. It is a route whose exposure profile depends partly on anatomy, and the anatomy of the rectum is not uniform. The tissue encountered by a suppository placed deep into the canal does not share the same vascular connections as tissue encountered by one placed near the anal margin. Those differences are not minor variations within a single delivery environment. They represent meaningfully distinct biological territories, each with different implications for how absorbed material is handled before it reaches circulation.
The central problem with how suppositories are typically discussed is that placement is treated as a matter of comfort or convenience rather than a pharmacokinetic variable. Once that frame is imported, the route is permanently misread. The dose is optimized, the formulation is debated, the base material is discussed, and the one factor that determines which vascular territory the absorbed material is most likely to reach goes unexamined.
Borrowed Assumptions
Every delivery route carries ideas borrowed from adjacent categories. Topical preparations import expectations from transdermal design. Sublingual preparations import expectations from inhalation. Suppositories borrow most heavily from oral delivery, and those borrowed ideas are among the most distorting in the category.
The oral model is built around ingestion, digestion, and hepatic processing. Material is swallowed, processed through the GI tract, absorbed through the intestinal wall, and carried via portal circulation to the liver before it reaches the rest of the body. That sequence is so well established that it has become the default mental picture for anything placed inside the body through the GI system. Suppositories sit inside the body. They dissolve and release material into rectal tissue. The implicit conclusion is that the same sequence follows: absorption, portal drainage, hepatic processing, then systemic distribution.
That conclusion is not invented. It has partial biological basis. Portions of the rectum do drain into the portal system. But it is incomplete in a way that matters. The rectum is not a single absorptive zone with one vascular destination. It contains regions whose venous drainage routes differ, and those differences are consequential for how absorbed cannabinoids are handled. When a suppository is placed at a particular depth, it does not simply enter the body. It enters a specific tissue environment with specific vascular connections. Whether those connections route absorbed material toward hepatic processing or around it is partly a function of where the suppository sits.
The idea that rectal delivery is just a more interior version of oral delivery flattens this anatomy into irrelevance. It treats the canal as a uniform conduit rather than a structure with variable drainage geography. Once that flattening happens, the question of whether placement matters cannot even be formulated. The route appears to have one character, and the only variables worth adjusting seem to be formulation and dose.
Two Drainages, One Canal
The rectum is drained by three venous systems that connect to different parts of the circulatory tree. Understanding how they differ requires a brief picture of the anatomy before the pharmacokinetic implications become clear.
The superior rectal vein drains the upper rectum and connects to the inferior mesenteric vein, which feeds into the portal system. Material absorbed from upper rectal tissue and taken up by this drainage route passes through the liver before entering systemic venous circulation. The middle and inferior rectal veins drain the middle and lower rectum and the anal canal, connecting to the internal iliac and pudendal vessels instead. Those vessels drain into systemic venous circulation without passing through the liver first.
Within a relatively short distance, the rectum therefore contains tissue that connects to fundamentally different circulatory pathways. One path includes hepatic processing as a necessary stage before systemic distribution. The other does not. For cannabinoids subject to significant first-pass metabolism, that difference in drainage destination is not a pharmacological footnote. It is potentially the difference between a compound arriving in circulation in meaningful amounts and one being substantially reduced before it gets there.
Several qualifications bear stating clearly. The vascular territories in the rectum are not cleanly separated by a visible anatomical border. There is overlap, and individual variation is real. The proportion of absorbed material reaching each drainage system is not determined by depth alone. Suppository base composition affects how completely and quickly a preparation melts and spreads, and a preparation that melts slowly and pools may contact different tissue proportions than one that spreads widely. Migration after insertion, driven by rectal motility and posture, means the suppository or its released material does not necessarily remain at the original placement site. The extent to which cannabinoids are absorbed through upper versus lower rectal tissue also depends on contact time, tissue condition, and local perfusion, none of which are constants.
What the anatomy establishes is not a rule about where suppositories should be placed. It establishes that placement is a major variable in an already complex system. The vascular map creates the possibility space. What actually occurs within that space depends on multiple overlapping factors that interact differently across individuals and preparations.
What Depth May Change
Given the anatomical picture, the question of what placement depth may change becomes less about rules and more about probabilities. A suppository placed high in the rectum is more likely to contact tissue draining toward the portal system. One placed low is more likely to contact tissue draining toward systemic venous circulation without hepatic intermediation. Those tendencies are real, but they are tendencies rather than guaranteed outcomes.
Melting behavior is one of the first complicating variables. A suppository that melts quickly and spreads broadly distributes released material across a larger mucosal surface, increasing the likelihood of contact with tissue from multiple vascular zones. A preparation that melts slowly and stays locally concentrated produces a different contact pattern, potentially maintaining a closer relationship between placement depth and drainage destination, though retention of that position is itself variable.
Migration adds further unpredictability. Rectal motility can move a suppository or its released contents proximally or distally after insertion, and posture influences that movement. A suppository inserted at a particular depth may not remain there, and released material may contact tissue across a range the original placement did not anticipate. Retention time matters independently: a preparation retained longer has more opportunity for absorbed material to encounter tissue across multiple zones, while one expelled prematurely, or placed into a rectum that is not empty, may release material into an environment that limits contact regardless of initial depth.
What this produces is not a picture in which placement is irrelevant, but one in which placement is one among several strongly interacting determinants of exposure. Depth influences which vascular territory is most likely to be contacted. Melting behavior, migration, and retention shape how consistently that contact occurs and for how long. A preparation placed low but prone to rapid proximal migration may produce an exposure profile closer to a high placement than its initial depth would suggest. A preparation placed high but poorly formulated for mucosal contact may underperform regardless of vascular geography.
The correction to the inherited model is not a clean rule assigning outcomes to depths. It is the recognition that placement is a major variable in a system where several major variables interact, and that treating it as incidental leaves a large part of the delivery system unexamined.
Placement as Preparation
Route choice determines biological territory. What is administered and how it is administered places a compound in a specific environment with specific barriers, specific opportunities for absorption, and specific limits on where the material can go. Suppository delivery adds a second-order version of that principle: within this route, position within the route is itself a pharmacokinetic variable.
The biological territory accessed by a rectal preparation is not fixed by the route category alone. It shifts depending on where in the canal the preparation sits, how it behaves after placement, and how anatomy, motility, and formulation interact across the administration window. That is not a complication of the route. It is a structural feature of how the route works.
The reason placement has stayed out of the suppository conversation is that the conversation rarely reaches the anatomy. It stops at base materials, dose, and general route comparisons, none of which engage the question of which vascular territory the absorbed material is most likely to reach. The borrowed oral model fills that gap with a conclusion rather than an examination, and the examination never follows.
Treating placement as a preparation variable does not mean every user needs to make clinical decisions about depth. It means that anyone designing, evaluating, or interpreting rectal cannabinoid delivery needs to understand that the preparation does not stop at formulation. The physical interaction between a suppository and the tissue environment it contacts, including where in that environment it sits, how it melts, how far it migrates, and how long it is retained, is part of the delivery system. Formulation quality without attention to those variables produces an incomplete picture of how the route actually works.
Rectal delivery is not oral delivery made more interior. It is a distinct delivery system with its own anatomy, its own relationship between placement and vascular drainage, and its own set of interacting variables that shape whether absorbed material faces hepatic processing or largely bypasses it. Until placement is understood as part of that system, the route will continue to be read through borrowed conclusions rather than examined on the terms its own anatomy requires.
References & Citations and What They Support
Hua S. Frontiers in Pharmacology, 10:1196 (2019). Review of rectal physiology, local and systemic delivery, absorption variables, suppository bases, and pharmaceutical considerations for rectal formulations.
Supports: The article’s core distinction between rectal delivery as a route category and rectal exposure as a variable outcome shaped by anatomy, formulation, contact time, and local conditions.
Rathi R, Sanshita, Kumar A, Vishvakarma V, Huanbutta K, Singh I, Sangnim T. Pharmaceutics, 14(10):2210 (2022). Review of rectal drug delivery systems, clinical development, formulation types, physiological factors, and pharmaceutical variables influencing rectal absorption.
Supports: Preparation behavior belongs inside the delivery argument because base selection, dosage form design, spreading, release, and retention can alter the exposure pattern after placement.
ElSohly MA, Stanford DF, Harland EC, Hikal AH, Walker LA, Little TL Jr, Rider JN, Jones AB. Journal of Pharmaceutical Sciences, 80(10):942–945 (1991). Animal pharmacokinetic study examining rectal bioavailability of Δ9-THC delivered as a hemisuccinate ester in suppository form. Supports: Cannabinoid suppository delivery cannot be reduced to a simple claim that cannabinoids never reach circulation; systemic exposure depends on the compound, formulation strategy, and route behavior.
ElSohly MA, Gul W, Walker LA. Medical Cannabis and Cannabinoids, 1(1):44–53 (2018). Human pharmacokinetic and tolerability study comparing oral dronabinol with rectal THC-hemisuccinate suppositories for systemic Δ9-THC delivery.
Supports: Rectal cannabinoid exposure is possible under specific formulation conditions, while the need for a prodrug suppository reinforces the article’s caution against assuming ordinary suppository placement guarantees predictable systemic delivery.
Full References & Citations
Hua S. Physiological and pharmaceutical considerations for rectal drug formulations. Frontiers in Pharmacology. 2019;10:1196. doi:10.3389/fphar.2019.01196.
Rathi R, Sanshita, Kumar A, Vishvakarma V, Huanbutta K, Singh I, Sangnim T. Advancements in rectal drug delivery systems: clinical trials, and patents perspective. Pharmaceutics. 2022;14(10):2210. doi:10.3390/pharmaceutics14102210.
ElSohly MA, Stanford DF, Harland EC, Hikal AH, Walker LA, Little TL Jr, Rider JN, Jones AB. Rectal bioavailability of delta-9-tetrahydrocannabinol from the hemisuccinate ester in monkeys. Journal of Pharmaceutical Sciences. 1991;80(10):942–945. doi:10.1002/jps.2600801008.
ElSohly MA, Gul W, Walker LA. Pharmacokinetics and tolerability of Δ9-THC-hemisuccinate in a suppository formulation as an alternative to capsules for the systemic delivery of Δ9-THC. Medical Cannabis and Cannabinoids. 2018;1(1):44–53. doi:10.1159/000489037.
